Cargando…

Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study

The treatment options are currently limited, and the oncological outcomes remain unclear, for patients with metastatic urothelial carcinoma (mUC) with or without third-line systemic therapy. We aimed to evaluate the oncological outcomes in real-world daily clinical practice after platinum-based chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Toyohiro, Nakane, Keita, Enomoto, Torai, Tomioka, Masayuki, Taniguchi, Tomoki, Ishida, Takashi, Ozawa, Kaori, Takagi, Kimiaki, Ito, Hiroki, Takeuchi, Shinichi, Kawase, Makoto, Kawase, Kota, Kato, Daiki, Takai, Manabu, Iinuma, Koji, Yokoi, Shigeaki, Nakano, Masahiro, Koie, Takuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496337/ https://www.ncbi.nlm.nih.gov/pubmed/36140344 http://dx.doi.org/10.3390/biomedicines10092243

Ejemplares similares

The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma
por: Tomioka-Inagawa, Risa, et al.
Publicado: (2022)

The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2023)

Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer
por: Kawase, Makoto, et al.
Publicado: (2022)

Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2022)

Robot-Assisted Radical Prostatectomy for Potential Cancer Control in Patients with Metastatic Prostate Cancer
por: Takagi, Kimiaki, et al.
Publicado: (2022)

Diabetes Mellitus as a Predictive Factor for Urinary Tract Infection for Patients Treated with Kidney Transplantation
por: Ozawa, Kaori, et al.
Publicado: (2022)

Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2022)

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab
por: Iinuma, Koji, et al.
Publicado: (2021)

The Impact of Postoperative Renal Function Recovery after Laparoscopic and Robot-Assisted Partial Nephrectomy in Patients with Renal Cell Carcinoma
por: Kawase, Kota, et al.
Publicado: (2022)

Efficacy and Safety of the “Trisection Method” Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan
por: Nakane, Keita, et al.
Publicado: (2022)

Leptomeningeal Carcinomatosis in Urothelial Carcinoma of the Urinary Bladder: A Report of a Patient with a Fulminant Course Who Died of Cancer after Definitive Therapies
por: Tomioka, Masayuki, et al.
Publicado: (2021)

Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report
por: Takai, Manabu, et al.
Publicado: (2020)

Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2021)

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer
por: Sugino, Fumiya, et al.
Publicado: (2023)

Endoscopic combined intrarenal surgery for renal allograft lithiasis using “sheath-connection technique”: A case report
por: Sugino, Fumiya, et al.
Publicado: (2023)

Clinical Predictors of Grade Group Upgrading for Radical Prostatectomy Specimens Compared to Those of Preoperative Needle Biopsy Specimens
por: Tomioka, Masayuki, et al.
Publicado: (2022)

Solitary Fibrous Tumor of the Prostate: A Case Report and Literature Review
por: Takeuchi, Yasumichi, et al.
Publicado: (2021)

Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer
por: Tomioka, Masayuki, et al.
Publicado: (2021)

The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging
por: Kato, Daiki, et al.
Publicado: (2021)

Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center
por: Takeuchi, Shinichi, et al.
Publicado: (2022)

Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer
por: Takeuchi, Shinichi, et al.
Publicado: (2023)

Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system
por: Taniguchi, Tomoki, et al.
Publicado: (2022)

Temporary Tumor Shrinkage Following Enfortumab Vedotin Therapy for Metastatic Urothelial Carcinoma After Radical Cystectomy With Neoadjuvant Chemotherapy: A Case Report
por: Namiki, Sanae, et al.
Publicado: (2023)

Prognostic Factors for Resolution Delay of Lower Urinary Tract Symptoms in Patients with Prostate Cancer after Low-Dose-Rate Brachytherapy
por: Taniguchi, Tomoki, et al.
Publicado: (2023)

Perilesional Targeted Biopsy Combined with MRI-TRUS Image Fusion-Guided Targeted Prostate Biopsy: An Analysis According to PI-RADS Scores
por: Tomioka, Masayuki, et al.
Publicado: (2023)

The accuracy of prostate cancer diagnosis in biopsy-naive patients using combined magnetic resonance imaging and transrectal ultrasound fusion-targeted prostate biopsy
por: Uno, Hiromi, et al.
Publicado: (2021)

A Case of Localized Prostate Cancer Associated with Polymyalgia Rheumatica with Marked Symptomatic Improvement after Robot-Assisted Radical Prostatectomy
por: Kawase, Makoto, et al.
Publicado: (2021)

Gallbladder metastasis from renal cell carcinoma: A case report and literature review
por: Takagi, Kimiaki, et al.
Publicado: (2019)

A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab
por: Tomioka, Masayuki, et al.
Publicado: (2021)

Chronological Changes of Lower Urinary Tract Symptoms in Elderly Patients with Prostate Cancer after Low-Dose-Rate Prostate Brachytherapy
por: Tsuchiya, Kunihiro, et al.
Publicado: (2023)

Low Body Mass Index as a Predictive Factor for Postoperative Infectious Complications after Ureterorenoscopic Lithotripsy
por: Seike, Kensaku, et al.
Publicado: (2021)

Preoperative predictive factors of carcinoma in situ in the normal‐appearing mucosa in patients who underwent an initial transurethral resection for non‐muscle‐invasive bladder cancer under white light cystoscopy
por: Iinuma, Koji, et al.
Publicado: (2020)

Prognostic Value of the Controlling Nutritional Status (CONUT) Score in Patients at Dialysis Initiation
por: Takagi, Kimiaki, et al.
Publicado: (2022)

CALN1 hypomethylation as a biomarker for high-risk bladder cancer
por: Takagi, Kimiaki, et al.
Publicado: (2022)

The effectiveness of off-clamp and non-renorrhaphy technique regarding postoperative renal function in patients with partial nephrectomy
por: Iinuma, Koji, et al.
Publicado: (2022)

Retroperitoneal lipogranuloma mimicking recurrence of renal cell carcinoma after laparoscopic partial nephrectomy
por: Takagi, Kimiaki, et al.
Publicado: (2019)

Usefulness of robot‐assisted radical prostatectomy in a patient with oligometastatic castration‐resistant prostate cancer
por: Koie, Takuya, et al.
Publicado: (2020)

Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience
por: Ito, Masaya, et al.
Publicado: (2023)

Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study
por: Ito, Katsuhiro, et al.
Publicado: (2022)

A Case of Muscle-Invasive Bladder Cancer With Pelvic Lymph Node Involvement Treated With Pembrolizumab and Subsequent Radical Cystectomy and Maintained No Evidence of Disease After Surgery
por: Takeuchi, Shinichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pq97324v8k0imphrdaeqfr938q